A New Method of Surgically Treating Varicose Veins and Venous Ulcers - a Study to Assess Clinical and Economic Value
Launched by HULL UNIVERSITY TEACHING HOSPITALS NHS TRUST · Sep 24, 2008
Trial Information
Current as of April 24, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Primary, symptomatic, varicose veins.
- • Isolated Saphenofemoral junction (SFJ) incompetence leading to long saphenous (LSV) reflux on duplex ultrasound.
- • LSV of 4mm diameter at the knee.
- • Ability to give informed written consent.
- Exclusion Criteria:
- • Inability to give informed written consent.
- • Symptomatic or complicated varicose veins not attributable to SFJ/LSV reflux.
- • Evidence of deep venous reflux on duplex scan.
Trial Officials
Ian C Chetter, MBChB
Principal Investigator
University of Hull
About Hull University Teaching Hospitals Nhs Trust
Hull University Teaching Hospitals NHS Trust is a leading healthcare organization dedicated to delivering high-quality patient care, education, and research. Located in Hull, England, the Trust encompasses a range of hospitals and healthcare services, providing a comprehensive spectrum of clinical specialties. With a strong commitment to advancing medical science, the Trust actively sponsors and conducts clinical trials that aim to improve patient outcomes and contribute to evidence-based practice. By collaborating with academic partners and leveraging its state-of-the-art facilities, Hull University Teaching Hospitals NHS Trust fosters an innovative research environment that prioritizes patient safety and ethical standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hull, East Yorkshire, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials
Related Blog Entries
View all
